Davita Justin Drive Dialysis is a medicare approved dialysis facility center in Danville, Pennsylvania and it has 21 dialysis stations. It is located in Montour county at 32 Justin Drive Ste 101, Danville, PA, 17821. You can reach out to the office of Davita Justin Drive Dialysis at (272) 365-0153. This dialysis clinic is managed and/or owned by Davita. Davita Justin Drive Dialysis has the following ownership type - Profit. It was first certified by medicare in May, 2025. The medicare id for this facility is 732521 and it accepts patients under medicare ESRD program.
Dialysis Center Profile
| Name | Davita Justin Drive Dialysis |
|---|
| Location | 32 Justin Drive Ste 101, Danville, Pennsylvania |
|---|
| No. of Dialysis Stations | 21 |
|---|
| Medicare ID | 732521 |
|---|
| Managed By | Davita |
|---|
| Ownership Type | Profit |
|---|
| Late Shifts | No |
|---|
NPI Associated with this Dialysis Facility:
Dialysis facilities may have several NPI numbers. We have found possible NPI numbers associated with Davita Justin Drive Dialysis
from NPPES records by matching their name, address or phone number, so please use this information accordingly.
| NPI Number | 1992521249 |
| Match | Possible same name, address or phone number |
| Organization Name | Stallington Dialysis LLC |
| Doing Business As | Justin Drive Dialysis |
| Address | 32 Justin Dr Ste 101, Danville, Pennsylvania 17821 |
| Phone Number | (272) 365-0153 |
Services Offered
- Hemodialysis
- Peritoneal Dialysis
- Home Hemodialysis Training
Patient Distribution
Anemia Management
| Dialysis patients with Hemoglobin data | 18 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 11 |
Dialysis Adequacy
For adult patients on hemodialysis, Kt/V should be at least 1.2 and for peritoneal dialysis at least 1.7; that means they are receiving the right amount of dialysis. For pediatric patients, Kt/V should be at least 1.2 on hemodialysis and 1.8 on peritoneal dialysis.
Higher percentages are better.
- Hemodialysis
| Adult patients getting regular hemodialysis at the center | 55 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 300 |
| Percentage of adult hemodialysis patients with Kt/V greater than or equal to 1.2 | 76 |
- Peritoneal Dialysis
| Adult patients getting regular peritoneal dialysis at the center | 17 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 70 |
| Percentage of adult peritoneal dialysis patients with Kt/V greater than or equal to 1.7 | 50 |
Mineral and Bone Disorder
An important goal of dialysis is to maintain normal levels of various minerals
in the body, such as calcium. This shows the percentage of patients
treated at Davita Justin Drive Dialysis with elevated calcium levels.
| Patients in the hypercalcemia summary | 73 |
| Hypercalcemia patient months | 388 |
| Percentage of adult patients with serum calcium greater than 10.2 mg/dL | 16 |
| Patients in the serum phosphorus summary | 77 |
| Percentage of patients with serum phosphorus less than 3.5 mg/dL | 8 |
| Percentage of patients with serum phosphorus from 3.5 to 4.5 mg/dL | 23 |
| Percentage of patients with serum phosphorus from 4.6 to 5.5 mg/dL | 23 |
| Percentage of patients with serum phosphorus from 5.6 to 7 mg/dL | 27 |
| Percentage of patients with serum phosphorus greater than 7 mg/dL | 19 |
Vascular Access
The arteriovenous (AV) fistula is considered the best long-term vascular access for hemodialysis because it
allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access.
Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arteriovenous fistula and catheter summaries | 62 |
| Patient months included in arteriovenous fistula and catheter summaries | 312 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistula for their treatment | 30.2 |
| Percentage of patients receiving treatment through a vascular catheter for 90 days or longer | 36 |